DEPLOYDatabase

Deployment

B-TEMIA Keeogo at Montreal

Powered (motorized bilateral-knee) wearable exoskeleton for mobility assistance - walking, stairs, sit-to-stand, squatting - for people with stroke, MS, SCI or degenerative conditions. ~5.4 kg with hip battery. CE-marked; sold in Canada, Europe and Asia.

B-TEMIA Keeogo by B-TEMIA · Catalog entry · 3 sources · not yet field-verified · Exoskeletons

Track B-TEMIA Keeogo at Montreal

Recent coverage

See all coverage →

B-TEMIA Keeogo powered exoskeleton deployed at rehabilitation clinics in Montreal, Canada. FDA-cleared for stroke and MS patients.

Key facts

Technology
B-TEMIA Keeogo powered exoskeleton
Coverage
Montreal, Canada
Use Case
Rehabilitation clinics for stroke and MS patients
Regulatory
FDA-cleared

Exposure

Customer segment
healthcare
Scale tier
commercial 10 99

Each exposure value carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Safety record

No incidents on record for B-TEMIA Keeogo at Montreal.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Catalog entry · 3 sources · not yet field-verifiedhow tiers work →
Last updated
2026-08-21
Model
B-TEMIA Keeogo
Company
B-TEMIA
Location
Canada/Montreal
Operator
B-TEMIA
Status
operational
Operator type
maker operated
Scale at site
11 to 100 units
Site environment
indoor
Location precision
verified coordinates
First seen
2024-06-01
ID
221614f8-e4a5-4445-a1b6-bbfd4f93ba3f

Timeline

  1. Jun 2024
    First recorded
    B-TEMIA Keeogo first documented operating at Montreal.
  2. Jun 2026
    created
  3. Aug 2026
    Current status: operational, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Free to use on your site, with a link back to DEPLOY.

B-TEMIA Keeogo operates in Montreal. Explore the full verified map:

Sources (3)

  1. https://b-temia.com/
  2. https://keeogo.com/about-keeogo/clinical-studies
  3. https://b-temia.com/home/media-room/b-temias-keeogo-obtains-ce-marking-allowing-its-commercialization-in-eu-countries
Methodology: Verified · 3 sources (no primary) · last reviewed 2026-08-21

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-21

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

3
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for B-TEMIA Keeogo at Montreal.

Common questions

What is the B-TEMIA Keeogo deployment at Montreal?
B-TEMIA Keeogo, built by B-TEMIA, is recorded as a deployment at Montreal on the DEPLOY registry. B-TEMIA operates the deployment directly.
Who operates B-TEMIA Keeogo at Montreal?
B-TEMIA, the manufacturer of B-TEMIA Keeogo, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
When did the B-TEMIA Keeogo deployment at Montreal go live?
The deployment is recorded as starting June 1, 2024 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
Have there been incidents at the B-TEMIA Keeogo deployment at Montreal?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.

Machine-readable surfaces